INCLISIRAN SODIUM, BEMPEDOIC ACID, ATORVASTATIN, ROSUVASTATIN, EZETIMIBE clinical trials

A randomized, multicenter, open-label trial comparing the effectiveness of Inclisiran to bempedoic acid on LDL cholesterol (LDL-C) lowering in participants with atherosclerotic cardiovascular disease (VICTORION-CHALLENGE)

This study, called VICTORION-CHALLENGE, is comparing two medicines, Inclisiran and Bempedoic acid, to see which one is better at lowering 'bad' cholesterol (LDL-C) in people who have had heart or circulation problems. We want to find out how much they can reduce cholesterol after about five months.